$GILD Recent Headlines 3D Systems down on weak o
Post# of 44957
Posted On: 02/12/2014 11:12:03 AM
$GILD Recent Headlines
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Beware the dead-cat bounce 1:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 1:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Gilead a Given for Hepatitis C Favorite 48 min ago - Barrons.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Today - Zacks.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Today - Zacks.com
Short Sellers Shy Away From Biotechs 6:04 a.m. Today - 247WallSt.com
Buy GILD Now Before Its Next Breakout 7:16 p.m. Feb. 11, 2014 - InvestorPlace.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. Feb. 11, 2014 - TheStreet.com
Gilead Seeks U.S. Approval - Analyst Blog 4:00 p.m. Feb. 11, 2014 - Zacks.com
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Gilead +2.8% on positive talk, Sovaldi would make numbers look even better 3:59 p.m. Feb. 10, 2014 - Seeking Alpha
Gilead Going to $90, or $110 2:37 p.m. Feb. 10, 2014 - 247WallSt.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Top Analyst Upgrades and Downgrades: Fairway Group, J.P. Morgan, Red Robin, Vodafone, More 7:57 a.m. Feb. 10, 2014 - 247WallSt.com
The Hep C Race Is Heating Up: AbbVie Vs. Gilead 7:47 a.m. Feb. 10, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Rocket Fuel Inc, Gilead Sciences Inc, ServiceNow Inc, and First ... 10:57 p.m. Feb. 9, 2014 - GuruFocus.com
You Can No Longer Ignore Biotech 4:32 p.m. Feb. 7, 2014 - GuruFocus.com
Is Gilead Sciences (GILD) a Great Growth Stock? - Tale of the Tape 8:38 a.m. Feb. 7, 2014 - Zacks.com
Stock Market News for February 06, 2014 - Market News 10:06 a.m. Feb. 6, 2014 - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 9:30 a.m. Feb. 6, 2014 - Zacks.com
'Mad Money' Lightning Round: We Don't Want Molycorp 6:00 a.m. Feb. 6, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Today - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Beware the dead-cat bounce 1:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 1:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Gilead a Given for Hepatitis C Favorite 48 min ago - Barrons.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Today - Zacks.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Today - Zacks.com
Short Sellers Shy Away From Biotechs 6:04 a.m. Today - 247WallSt.com
Buy GILD Now Before Its Next Breakout 7:16 p.m. Feb. 11, 2014 - InvestorPlace.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. Feb. 11, 2014 - TheStreet.com
Gilead Seeks U.S. Approval - Analyst Blog 4:00 p.m. Feb. 11, 2014 - Zacks.com
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Gilead +2.8% on positive talk, Sovaldi would make numbers look even better 3:59 p.m. Feb. 10, 2014 - Seeking Alpha
Gilead Going to $90, or $110 2:37 p.m. Feb. 10, 2014 - 247WallSt.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Top Analyst Upgrades and Downgrades: Fairway Group, J.P. Morgan, Red Robin, Vodafone, More 7:57 a.m. Feb. 10, 2014 - 247WallSt.com
The Hep C Race Is Heating Up: AbbVie Vs. Gilead 7:47 a.m. Feb. 10, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Rocket Fuel Inc, Gilead Sciences Inc, ServiceNow Inc, and First ... 10:57 p.m. Feb. 9, 2014 - GuruFocus.com
You Can No Longer Ignore Biotech 4:32 p.m. Feb. 7, 2014 - GuruFocus.com
Is Gilead Sciences (GILD) a Great Growth Stock? - Tale of the Tape 8:38 a.m. Feb. 7, 2014 - Zacks.com
Stock Market News for February 06, 2014 - Market News 10:06 a.m. Feb. 6, 2014 - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 9:30 a.m. Feb. 6, 2014 - Zacks.com
'Mad Money' Lightning Round: We Don't Want Molycorp 6:00 a.m. Feb. 6, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Today - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
(0)
(0)